Literature DB >> 16138911

Evidence of a common founder for SCA12 in the Indian population.

S Bahl1, K Virdi, U Mittal, M P Sachdeva, A K Kalla, S E Holmes, E O'Hearn, R L Margolis, S Jain, A K Srivastava, M Mukerji.   

Abstract

Spinocerebellar ataxia type 12 (SCA12) is an autosomal dominant cerebellar ataxia associated with the expansion of an unstable CAG repeat in the 5' region of the PPP2R2B gene on chromosome 5q31-5q32. We found that it accounts for approximately 16% (20/124) of all the autosomal dominant ataxia cases diagnosed in AIIMS, a major tertiary referral centre in North India. The length of the expanded allele in this population ranges from 51-69 CAG triplets. Interestingly, all the affected families belong to an endogamous population, which originated in the state of Haryana, India. We identified four novel SNPs and a dinucleotide marker spanning approximately 137 kb downstream of CAG repeat in the PPP2R2B gene. Analysis of 20 Indian SCA12 families and ethnically matched normal unrelated individuals revealed one haplotype to be significantly associated with the affected alleles (P= 0.000), clearly indicating the presence of a common founder for SCA12 in the Indian population. This haplotype was not shared by the American pedigree with SCA12. Therefore, the SCA12 expansion appears to have originated at least twice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16138911     DOI: 10.1046/j.1529-8817.2005.00173.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  19 in total

Review 1.  The Indian Genome Variation database (IGVdb): a project overview.

Authors: 
Journal:  Hum Genet       Date:  2005-08-25       Impact factor: 4.132

2.  Utilizing linkage disequilibrium information from Indian Genome Variation Database for mapping mutations: SCA12 case study.

Authors:  Samira Bahl; Ikhlak Ahmed; Mitali Mukerji
Journal:  J Genet       Date:  2009-04       Impact factor: 1.166

3.  Spinocerebellar ataxias type 8, 12, and 17 and dentatorubro-pallidoluysian atrophy in Czech ataxic patients.

Authors:  Zuzana Musova; Zdenek Sedlacek; Radim Mazanec; Jiri Klempir; Jan Roth; Pavlina Plevova; Martin Vyhnalek; Marta Kopeckova; Ludmila Apltova; Anna Krepelova; Alena Zumrova
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

4.  Abnormal DaTSCAN and Atypical Parkinsonism in SCA12.

Authors:  Anna Latorre; Claudia Del Gamba; Elisa Menozzi; Bettina Balint; Florian Brugger; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2019-03-28

5.  Tremor in Spinocerebellar Ataxia Type 12.

Authors:  Lorraine V Kalia; Cheryl Rockman-Greenberg; Andrew Borys; Anthony E Lang
Journal:  Mov Disord Clin Pract       Date:  2014-04-10

6.  Dystonic Tremor and Spasmodic Dysphonia in Spinocerebellar Ataxia Type 12.

Authors:  Christos Ganos; Tabish A Saifee; Panagiotis Kassavetis; Roberto Erro; Amit Batla; Carla Cordivari; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2014-04-10

Review 7.  Essential Tremor Within the Broader Context of Other Forms of Cerebellar Degeneration.

Authors:  Elan D Louis; Phyllis L Faust
Journal:  Cerebellum       Date:  2020-12       Impact factor: 3.847

8.  Exploration of CAG triplet repeat in nontranslated region of SCA12 gene.

Authors:  Waseem Gul Lone; Imran Ali Khan; Subhadra Poornima; Noor Ahmad Shaik; Angmuthu Kanikannan Meena; Kaipa Prabhakar Rao; Qurratulain Hasan
Journal:  J Genet       Date:  2016-06       Impact factor: 1.166

9.  Paradigm for disease deconvolution in rare neurodegenerative disorders in Indian population: insights from studies in cerebellar ataxias.

Authors:  Renu Kumari; Deepak Kumar; Samir K Brahmachari; Achal K Srivastava; Mohammed Faruq; Mitali Mukerji
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

10.  Spectrum and prevalence of autosomal dominant spinocerebellar ataxia in Hokkaido, the northern island of Japan: a study of 113 Japanese families.

Authors:  Rehana Basri; Ichiro Yabe; Hiroyuki Soma; Hidenao Sasaki
Journal:  J Hum Genet       Date:  2007-09-05       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.